A subsequent study in 10 MS patients explored both blood and cerebrospinal fluid (CSF) and revealed that neither had thromboplastin activity, nor significant abnormalities in blood platelet, coagulation factors, serum platelet-like activity nor fibrinogen levels (131). This evidence concerns the gene F3 and myeloid sarcoma.